A femtomolar-acting neuroprotective peptide

Journal of Clinical Investigation

Volumn 97, Issue 10, 1996, Pages 2299-2307

  Brenneman, Douglas E ^a   Gozes, Illana ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

activity dependent neurotrophic factor; astrocyte; neuronal survival; vasoactive intestinal peptide

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOPROTEIN GP 120; HEAT SHOCK PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; TETRODOTOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG POTENCY; ISOELECTRIC FOCUSING; MACROGLIA; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; RAT;

EID: 0029883129     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118672     Document Type: Article

References (62)

1. Levi-Montalcini, R. 1979. Recent studies on the NGF-target cells interaction. Differentiation. 13:51-53.
2. Lin, L.F., D. Mismer, J.D. Lile, L.G. Armes, E.T. Butler III, J.L. Vannice, and F. Collins. 1989. Purification, cloning and expression of ciliary neurotrophic factor (CNTF). Science (Wash. DC). 24:1023-1025.
3. Wallicke, P.A., and A. Baird. 1991. Internalization and processing of basic fibroblast growth factor by neurons and astrocytes. J. Neurosci. 11:2249-2258.
4. Ishii, D.N., G. Glazner, and S.F. Pu. 1994. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol. & Ther. 62:125-144.
5. Leibrock, J., F. Lottspeich, A. Hohn, M. Hofer, B. Hengerer, P. Masiakowski, H. Thoenen, and Y.A. Barde. 1989. Molecular cloning and expression of brain-derived neurotrophic factor. Nature (Lond.). 341:149-152.
6. Lin, L.F., D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (Wash. DC). 260:1130-1132.
7. Henderson, C.E., W. Camu, C. Mettling, A. Gouin, K. Poulsen, M. Karihaloo, J. Rullamas, T. Evans, S.B. McMahon, M.P. Aramanini et al. 1993. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature (Lond.). 363:266-269.
8. Brenneman, D.E., M. Schultzberg, T. Bartfai, and I. Gozes. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58:454-460.
9. Patterson, P.H. 1992. The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 2: 94-97.
10. Brenneman, D.E., E.A. Neale, W.H. Habig, L.M. Bowers, and P.G. Nelson. 1983. Developmental and neurochemical specificity of neuronal deficits produced by electrical impulse blockade in dissociated spinal cord cultures. Dev. Brain Res. 9:13-27.
11. Brenneman, D.E., S. Fitzgerald, and P.G. Nelson. 1984. Interaction between trophic action and electrical activity in spinal cord cultures. Dev. Brain Res. 15:211-217.
12. Agoston, D.V., L.E. Eiden, D.E., Brenneman, and I. Gozes. 1991. Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures. Mol. Brain Res. 10:235-240.
13. Brenneman, D.E., L.E. Eiden, and R.E. Siegel. 1985. Neurotrophic action of VIP on spinal cord cultures. Peptides (Tarryt.). 6 (Suppl. 2):35-39.
14. Brenneman, D.E., and L.E. Eiden. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA. 83:1159-1162.
15. Said, S.I., and V. Mutt. 1988. Vasoactive intestinal peptide and related peptides. Ann. NY Acad. Sci. 527:1-691.
16. Said, S.I. 1994. VIP and messenger plasticity. Trends Neurosci. 17:339.
17. Gozes, I., S.K. McCune, L. Jacobson, D. Warren, T.W. Moody, M. Fridkin, and D.E. Brenneman. 1991. An antagonist to vasoactive intestinal peptide: effects on cellular functions in the central nervous system. J. Pharmacol. Exp. Therap. 257:959-966.
18. Brenneman D.E., E.A. Neale, G.A. Foster, S.W. d'Autremont, and G.L. Westbrook. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104:1603-1610.
19. Brenneman, D.E., T. Nicol, D. Warren, and L.M. Bowers. 1990. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:386-394.
20. Brenneman, D.E., J.M. Hill, G.W. Glazner, I. Gozes, and T.W. Phillips. 1995. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13:187-200.
21. Festoff, B.E., P.G. Nelson, and D.E. Brenneman. 1995. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin I. J. Neurobiol. In press.
22. Brenneman, D.E., G.L. Westbrook, S.P. Fitzgerald, D.L. Ennist, K.L. Elkins, M.R. Ruff, and C.B. Pert. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (Lond.). 335:639-642.
23. Gozes, I., A. Bardea, A. Reshef, R. Zamostiatno, S. Zhukovsky, S. Rubinraut, M. Fridkin, and D.E. Brenneman. 1996. Novel neuroprotective strategy for Alzheimer's disease: inhalation of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA. 93:427-432.
24. Brenneman, D.E., S.K. McCune, and I. Gozes. 1990. Acquired immune deficiency syndrome and the developing nervous system. Int. Rev. Neurobiol. 32:305-353.
25. Everall, I.P., P.J. Luthert, and P.L. Lantos. 1991. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337:1119-1121.
26. Schneidert, J., O. Kaaden, T.D. Copeland, S. Oroszlan, and G. Hunsmann. 1986. Shedding and interspecies type sero-reactivity of the envelope glycoprotein gp120 of the human immunodeficiency virus. J. Gen. Virol. 67:2533-2538.
27. Brenneman, D.E., J.M. Buzy, M.R. Ruff, and C.B. Pert. 1988. Peptide T sequences prevent neuronal cell death produced by the envelope protein (gp120) of the human immunodeficiency virus. Drug Dev. Res. 15:361-369.
28. Hill, J.M., R.F. Mervis, R. Avidor, T.W. Moody, and D.E. Brenneman. 1993. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603:222-233.
29. Lipton, S.A., N.J. Sucher, P.K. Kaiser, and E.B. Dreyer. 1991. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:111-118.
30. Gozes, I., A. Reshef, D. Salah, S. Rubinraut, and M. Fridkin. 1994. Stearyl-norleucine-VIP, a novel VIP analogue for non-invasive impotence treatment. Endocrinology. 134:2121-2125.
31. Gozes, I., G. Lilling, R. Glazer, A. Ticher, I.E., Ashkenazi, A. Davidson, S. Rubinraut, M. Fridkin, and D.E. Brenneman. 1995. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J. Pharmacol. Exp. Ther. 273:161-167.
32. Kowall, N.W., M.F. Beal, J. Buscigilio, L.K. Duffy, and B.A. Yankner. 1991. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:7247-7251.
33. Selkoe, D.J. 1993. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:403-409.
34. Schmechel, D.E., A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber, and A.D. Roses. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 15:9649-9653.
35. Shapira, J. 1994. Research trends in Alzheimer's disease. J. Gerontol. Nurs. 20:4-9.
36. Brumback, R.A., and R.W. Leech. 1994. Alzheimer's disease: pathophysiology and hope for therapy. J. Okla. State Med. Assoc. 87:103-111.
37. Nordberg, A., A. Lilja, H. Lundqvist, P. Hartvig, K. Amberla, M. Viitanen, U. Warpman, M. Johansson, E. Hellstrom-Lindahl, P. Bjurling et al. 1992. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer's patients as visualized by positron emission tomography. Neurobiol. Aging. 13:747-758.
38. Nordberg, A. 1993. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET. Acta Neurol. Scand. 149(Suppl.):62-65.
39. McCarthy, K.D., and L.M. Partlow. 1976. Preparation of pure neuronal and non-neuronal cultures from embryonic chick sympathetic ganglia: a new method based on both differential cell adhesiveness and the formation of homotypic neuronal aggregates. Brain Res. 114:391-414.
40. Romijn, H.J., A.M.M.C. Habets, M.T. Mud, and P.S. Wolters. 1982. Nerve outgrowth, synaptogenesis and bioelectric activity in fetal rat cerebral cortex tissue cultured in serum-free, chemically defined medium. Dev. Brain Res. 2:583-589.
41. Schmechel, D., P.J. Marangos, A.P. Zis, M. Brightman, and F.K. Goodwin. 1978. Brain enolases as specific markers of neuronal and glial cells. Science (Wash. DC). 199:313-315.
42. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
43. McManaman, J.L., F.G. Crowford, S.S. Stewart, and S.H. Appel. 1988. Purification of a skeletal muscle polypeptide which stimulates choline acetyl-transferase activity in cultured spinal cord neurons. J. Biol. Chem. 12:5890-5897.
44. Venner, T.J., and R.S. Gupta. 1990. Nucleotide sequence of rat hsp60 (chaperonin, GroEL homolog) CDNA. Nucleic Acids Res. 18:5309.
45. Gozes, I., and D.E. Brenneman. 1989. VIP molecular biology and neurobiological function. Mol. Neurobiol. 3:201-236.
46. Pike, C.J., D. Burdick, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-1687.
47. Zeilstra-Ryalls, J., O. Fayet, and C. Georgopoulos. 1991. The universally conserved GroE (Hsp60) chaperonins. Annu. Rev. Microbiol. 45:301-325.
48. Lindquist, S., and E.A. Craig. 1988. The heat shock proteins. Annu. Rev. Genet. 22:631-677.
49. Uney, J.B., J.N. Kew, K. Staley, P. Tyers, and M.V. Sofroniew. 1993. Transfection-mediated expression of human Hsp 70i protects rat dorsal root ganglia neurones and glia from severe heat stress. FEBS Lett. 334:313-316.
50. Cavanagh, A.C., and H. Morton. 1994. The purification of early pregnancy factor to homogeneity from human platelets and identification as chaper-onin 10. Eur. J. Biochem. 222:551-560.
51. Highwater, L.E., and P.T. Guidon. 1989. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia axon transfer proteins. J. Cell. Physiol. 138:257-266.
52. Prabhakar, S., E. Kurien, R.S. Gupta, S. Zielinski, and M.S. Freedman. 1994. Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology. 44:1644-1648.
53. Harrison, P.J., A.W. Procter, T. Exworthy, and G.W. Roberts. 1993. Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state. Neuropathol. Appl. Neurobiol. 19:10-21.
54. Lin, Y.-Z., S.Y. Yao, R.A. Veach, T.R. Torgerson, and J. Hawiger. 1995. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270:14255-14258.
55. Letourneur, F., and R.D. Klausner. 1992. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell. 69:1143-1157.
56. Dreyer, E.B., P.K. Kaiser, J.T. Offerman, and S.A. Lipton. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science (Wash. DC). 248:364-368.
57. Pert, C.B., C.C. Smith, M.R. Ruff, and J.M. Hill. 1988. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Ann. Neurol. 23(Suppl.):71-73.
58. ++ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26:325-338.
59. Carrette, B., P. Poulain, and A. Delacourte. 1993. Electrophysiological effects of 25-35 amyloid-beta-protein on guinea pig lateral septal neurons. Neurosci. Lett. 151:111-114.
60. Mattson, M.P., B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel. 1992. Beta amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389.
61. Valerio, A., A. Alberici, M. Paterlini, M., Grilli, P. Galli, M. Pizzi, M. Memo, and P. Spano. 1995. Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. Neuroreport. 6:1317-1321.
62. Lee, R.K., R.J. Wurtman, A.J. Cox, and R.M. Nitsch. 1995. Amyloid precursor protein processing is stimulated by metabotrophic glutamate receptors. Proc. Natl. Acad. Sci. USA. 15:8083-8087.